 A3G combats HIV infection by interacting with and mutating the virus' RNA.The mutations genetically damage the virus protein and render HIV unable to replicate which halts the spread of the virus.In laboratory testing, OyaGen was able to use drug therapy to shield A3G from HIV, which allowed A3G to function normally and halt the spread of the virus.